A serious shortage of commonly used chemotherapy drugs that began several years ago and worsened in 2010 is taking a toll on medical facilities and causing concerns among patients and doctors alike, according to representatives from government and professional groups. The continued shortfall is part of a more widespread shortage of drugs, including those frequently used in anesthesia and to treat dangerous infections, and has raised anxiety about patient care and clinical trials in which the drugs, many of them generic, are important components of treatment. Read more > >
The editor-in-chief of NCI's Physician Data Query (PDQ) Screening and Prevention Editorial Board talks about the types of effective cancer screening tests available and the risks that are sometimes associated with cancer screening. See the video > >
A MESSAGE TO READERS
- NCI Director Announces New Senior Staff Member
- Recap of Last Month's President's Cancer Panel Meeting
- In Memoriam: Susan Lowell Butler
- 250 Issues and Counting!
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at firstname.lastname@example.org.